Drug recall · September 9, 2026
Prasugrel Tablets recall
Why: Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.
- Lots / codes
Lot #: 3225272, Exp. September 30, 2026
- Quantity
- 47,662 bottles
- Company
- Mylan Pharmaceuticals Inc, Morgantown, WV
- Distribution
- Nationwide within the U.S
- Initiated
- August 17, 2026 · Voluntary: Firm initiated
- Classified
- September 11, 2026
- Reported
- September 9, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Prasugrel
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.